STAN S31 SYSTEM

FDA Premarket Approval P020001 S007

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for various hardware, software, and labeling upgrades includingintegration of maternal non-invasive blood pressure and oxygen saturation monitoring andalarms. The device, as modified, will be marketed under the trade name stan s31 and isindicated for:monitoring of fetus and mother throughout labor and delivery. The following parameterscan be monitored with stan s31: 1) fetal heart rate; 2) fetal ecg waveform; 3) uterine activity; 4) maternal non-invasive blood pressure; 5) maternal spo2; and 6) maternal heart rate. The stan s31 fetal heart monitor fetal ecg analysis feature (st analysis) isindicated as an adjunct to fetal heart rate monitoring to determine whether obstetricalintervention is warranted when there is increased risk of developing metabolic acidosis. St analysis is intended for use in patients with:1) planned vaginal delivery;2) >36 weeks gestation;3) singleton fetus;4) vertex presentation; and5) ruptured amniotic membranes.

DeviceSTAN S31 SYSTEM
Generic NameAnalyzer, Data, Obstetric
ApplicantNEOVENTA MEDICAL AB
Date Received2009-07-23
Decision Date2010-02-01
PMAP020001
SupplementS007
Product CodeHEO 
Advisory CommitteeObstetrics/Gynecology
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product Yes
Applicant Address NEOVENTA MEDICAL AB norra Agatan 32 se-431 35 molndal 

Supplemental Filings

Supplement NumberDateSupplement Type
P020001Original Filing
S009 2011-09-21 Real-time Process
S008 2011-07-07 30-day Notice
S007 2009-07-23 Normal 180 Day Track
S006 2009-09-11 Real-time Process
S005 2008-02-04 Real-time Process
S004 2007-10-11 Normal 180 Day Track
S003
S002 2007-08-13 Real-time Process
S001 2007-06-04 30-day Notice

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.